Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19-Reference-Cited by-同舟云学术

Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19

Published:2021-02 Issue:1 Volume:14 Page:40-55
ISSN:1756-5383
Container-title:Journal of Evidence-Based Medicine
language:en
Short-container-title:J Evid Based Med.

Author:

Luo Xufei¹^ORCID,Liu Yunlan¹,Ren Mengjuan¹,Zhang Xianzhuo²,Janne Estill³,Lv Meng¹,Wang Qi⁴⁵,Song Yang⁶,Mathew Joseph L.⁷,Ahn Hyeong Sik⁸⁹,Lee Myeong Soo¹¹⁰¹¹,Chen Yaolong¹¹²¹³¹⁴^ORCID

Affiliation:

1. School of Public Health Lanzhou University Lanzhou China

2. The First School of Clinical Medicine Lanzhou University Lanzhou China

3. Institute of Global Health University of Geneva Geneva Switzerland

4. Department of Health Research Methods, Evidence and Impact Faculty of Health Sciences McMaster University Hamilton Canada

5. McMaster Health Forum McMaster University Hamilton Canada

6. Iberoamerican Cochrane Centre ‐ Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau) Barcelona Spain

7. Advanced Pediatrics Centre PGIMER Chandigarh Chandigarh India

8. Department of Preventive Medicine Korea University Seoul Korea

9. Korea Cochrane Centre Seoul Korea

10. Korea Institute of Oriental Medicine Daejeon Korea

11. University of Science and Technology Daejeon Korea

12. Institute of Health Data Science Lanzhou University Lanzhou China

13. Evidence‐Based Medicine Center, School of Basic Medical Sciences Lanzhou University Lanzhou China

14. Key Laboratory of Evidence‐Based Medicine & Knowledge Translation of Gansu Province Lanzhou China

Publisher

Wiley

Subject

Health Policy,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jebm.12419

Reference53 articles.

1. World Health Organization.Coronavirus disease (COVID‐19) pandemic. Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019(accessed October 29 2020).

2. World Health Organization.Clinical management of severe acute respiratory infection (SARI) when COVID‐19 disease is suspected: interim guidance March 13 2020. Available from:https://apps.who.int/iris/bitstream/handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-chi.pdf(accessed September 15 2020).

3. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline

4. WHO.Clinical management of COVID‐19 interim guidance.2020 Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance. (accessed September 15 2020).

5. US CDC.Interim Guidelines for management of confirmed Coronavirus Disease (COVID‐19) clinical care guidance.2020 Available from:https://www.cdc.gov/coronavirus/2019-ncov/communication/guidance-list.html?Sort=Date%3A%3Adesc(accessed September 15 2020).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of expert opinion in infectious diseases clinical guidelines—A meta-epidemiological study;PLOS ONE;2024-06-27

2. How consistent are the key recommendations, and what is the quality of guidelines and expert consensus regarding paediatric cow’s milk protein allergy?;European Journal of Pediatrics;2024-05-29

3. Sysmex‐derived COVID‐19 prognostic score as an early prognostic marker for severity of the COVID‐19 disease;International Journal of Laboratory Hematology;2023-11-03

4. Prospective collaborative recommendation development: a novel model for more timely and trustworthy guidelines;Journal of Clinical Epidemiology;2023-10

5. Discovering associations between radiological features and COVID‐19 patients' deterioration;Health Science Reports;2023-05-08